Apoptosis Study on the Normal and Diabetics Type 2 Patients

Bashar Oda Jawad

doi:10.5958/0974-360X.2018.00460.2

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Apoptosis Study on the Normal and Diabetics Type 2 Patients

Author(s): Bashar Oda Jawad

Email(s): basharaltaaie@yahoo.com

DOI: 10.5958/0974-360X.2018.00460.2

Address: Bashar Oda Jawad
Department of Biology, College of Sciences, Babylon University
*Corresponding Author

Published In: Volume - 11, Issue - 6, Year - 2018

View HTML

View PDF

ABSTRACT:
The incidence ofapoptosis in peripheral blood lymphocytes for normal anddiabetic type 2 patients was conceder in this study .cells viability for normal and test groups showed 4.25%±0.64 for normal and8.9166% ± 1.14 for DT2 patients,the occurrences of apoptosis in control and test groups were also investigated a DNA binding stain (Hoescht stain ).The percentages ofapoptotisisin lymphocytes showed asignificant difference between normal (3.833%±0.76) and diabetic (11.4166%±1.42). A high proportion of apoptotic lymphocytes in diabetic type 2 patients may explain the impaired immune function in diabetic patients.

Keywords:

Cite this article:
Bashar Oda Jawad. Apoptosis Study on the Normal and Diabetics Type 2 Patients.Research J. Pharm. and Tech 2018; 11(6): 2493-2495. doi: 10.5958/0974-360X.2018.00460.2

Cite(Electronic):
Bashar Oda Jawad. Apoptosis Study on the Normal and Diabetics Type 2 Patients.Research J. Pharm. and Tech 2018; 11(6): 2493-2495. doi: 10.5958/0974-360X.2018.00460.2 Available on: https://rjptonline.org/AbstractView.aspx?PID=2018-11-6-61